3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Cancer - Colorectal cancer -

Calcium use may cut cancer risk in women

Cancer • • Colorectal cancerFeb 24, 09

Calcium consumption may reduce the risk of all cancers in women and the risk of cancers of the digestive tract in women and men, according to a report in the Archives of Internal Medicine.

“Our study is one of the first cohort studies to examine dairy food and calcium intakes in relation to total cancer as well as (uncommon) cancers,” Dr. Yikyung Park, from the National Cancer Institute, Bethesda, Maryland, and colleagues note.

Using data from the National Institutes of Health-American Association of Retired Persons Diet and Health Study, the researchers assessed the impact of dairy food and calcium intake on the risk of cancer in 293,907 men and 198,903 women.

During an average follow-up period of 7 years, 36,965 men and 16,605 women developed cancer, the report shows.

Calcium intake was tied to a reduced risk of cancer, in general, in women, but beyond intake of 1300 mg per day, no beneficial effect was seen.

As noted, both men and women had reduced risks of digestive system cancers. Men and women who consumed the highest amounts of calcium were 16 and 23 percent less likely, respectively, to develop these cancers relative to their peers who consumed the lowest amounts.

“Our findings suggest that calcium intake consistent with current recommendations is associated with a lower risk of total cancer in women and cancers of the digestive system, especially colorectal cancer, in both men and women,” the researchers conclude.

SOURCE: Archives of Internal Medicine, February 23, 2009.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  Metabolic profiles distinguish early stage ovarian cancer with unprecedented accuracy
  Moffitt researchers develop first genetic test to predict tumor sensitivity to radiation therapy
  New drug for neuroblastoma shows promise in phase I study
  Experimental treatment sends deadly leukemia into remission
  Study could reduce unnecessary cancer screening
  UA researchers discover component of cinnamon prevents colorectal cancer in mice
  Profiling approach to enable right lung cancer treatment match
  Fat grafting technique improves results of breast augmentation
  Germline TP53 mutations in patients with early-onset colorectal cancer
  Clinical trial suggests combination therapy is best for low-grade brain tumors
  UW research shows sensor technology may help improve accuracy of clinical breast exams

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site